Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection

Beneficial Effect of Luteal-phase Gonadotropin-releasing Hormone Agonist Administration on Implantation Rate Afterintracytoplasmic Sperm Injection

Objective: To evaluate the effect of gonadotropin-releasing hormone (GnRH) agonist, administered in the luteal phase, on intracytoplasmic sperm injection (ICSI) outcome. Materials and Methods: One hundred and eighty women undergoing ovarian stimulation for ICSI were enrolled in this study. Patients...

Full description

Bibliographic Details
Main Authors:	Dehghani Firouzabadi Razieh, Ayazi Rozbahani Maryam, Tabibnejad Nasim
Format:	Article
Language:	English
Published:	Elsevier 2009-09-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Subjects:	embryo implantation GnRH agonist intracytoplasmic sperm injection luteal phase support
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455909602977

Similar Items

Effects of gonadotropin-releasing hormone agonist (GnRH-a) as luteal phase support in intracytoplasmic sperm injection (ICSI) cycles: a randomized controlled trial
by: Nasrin Saharkhiz, et al.
Published: (2020-06-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
by: Dattaprasad B Inamdar, et al.
Published: (2012-01-01)

Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
by: Abdelhamid Benmachiche, et al.
Published: (2017-06-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation
by: I-Ting Liang, et al.
Published: (2015-10-01)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
by: Barbara Lawrenz, et al.
Published: (2018-02-01)

Klinische Studien/Klinische Praxis: Expertenkommentar zur Metaanalyse "Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis"
by: Just A
Published: (2015-01-01)

Mini-dose long gonadotropin-releasing hormone (GnRH) agonist versus agonist flare stimulation protocol for in vitro fertilization poor responders
by: Mona Mohamed Shaban
Published: (2014-12-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study
by: Maren Shapiro, et al.
Published: (2021-05-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01)

Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross-sectional study
by: Mohamed Atef Behery, et al.
Published: (2019-09-01)

Protocol shift from agonist to antagonist or vice versa after an unsuccessful intracytoplasmic sperm injection cycle on the same patient does not improve outcome
by: Yavuz Emre Şükür, et al.
Published: (2018-06-01)

Effects of multiple doses of gonadotropin-releasing hormone agonist on the luteal-phase support in assisted reproductive cycles: A clinical trial study
by: Maryam Eftekhar, et al.
Published: (2021-07-01)

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
by: Maira Huerta-Reyes, et al.
Published: (2019-10-01)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
by: Ming-Huei Lin, et al.
Published: (2019-01-01)

Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection
by: Deenadayal Mamata, et al.
Published: (2015-01-01)

Intraindividual Embryo Morphokinetics Are Not Affected by a Switch of the Ovarian Stimulation Protocol Between GnRH Agonist vs. Antagonist Regimens in Consecutive Cycles
by: Jens E. Dietrich, et al.
Published: (2020-04-01)

Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients
by: Woo HH, et al.
Published: (2017-02-01)

Immunohistochemical evaluation of leiomyoma tissue and normal myometrium in patients with uter-ine leiomyoma during hypo- and hyperestrogenic conditions caused by of use of gonadotropin-releasing hormone ana-logues
by: Medvedev M.V.
Published: (2012-01-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01)

The aptness of antagonistic protocol in intracytoplasmic sperm injection: Embryologic study
by: Tuqa Yousif Sharef
Published: (2019-04-01)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
by: Jie Lan, et al.
Published: (2021-05-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

Efficacy and safety of degarelix in patients with prostate cancer: Results from a phase III study in China
by: Yinghao Sun, et al.
Published: (2020-07-01)

OVARIAN STIMULATION FOR IVF-ET PROCEDURE
by: Robert Medved, et al.
Published: (2002-03-01)

Neurobiological study of fish brains gives insights into the nature of Gonadotropin-releasing hormone 1-3 neurons.
by: Tomomi eKarigo, et al.
Published: (2013-11-01)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
by: Ivana Bjelobaba, et al.
Published: (2018-04-01)

Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve
by: Wanlin Zhang, et al.
Published: (2020-05-01)

GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus
by: Shahar Kol, et al.
Published: (2017-04-01)

Effects of Gonadotropin Releasing Hormone Agonist (Buserelin) on Development of Ovarian Follicles of Adult Rats
by: Tahmineh Peirouvi, et al.
Published: (2016-08-01)

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
by: Panagiotis Drakopoulos, et al.
Published: (2019-02-01)

Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study
by: Li-Hong Wei, et al.
Published: (2016-02-01)

Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty
by: Jina Park, et al.
Published: (2017-03-01)

Increased Progesterone/Estradiol Ratio on the Day of hCG Administration Adversely Affects Success of In Vitro Fertilization–Embryo Transfer in Patients Stimulated with Gonadotropin-releasing Hormone Agonist and Recombinant Follicle-stimulating Hormone
by: Yu-Che Ou, et al.
Published: (2008-06-01)

Dienogest and the Risk of Reoperation in Endometriosis
by: Yong-Soo Seo, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_cvebllg9beo8imtunf1k50b05t